Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| SHPG | Shire PLC Sponsored ADR | 0.14% | 172.98 | 0.4% | $140.88m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.60% | 177.11 | 2.2% | $122.81m | |
| SAGE | SAGE Therapeutics, Inc. | 0.36% | 168.62 | 9.6% | $112.98m | |
| PRGO | Perrigo Co. Plc | -0.77% | 75.83 | 6.7% | $91.67m | |
| ENDP | Endo International Plc | 0.09% | 11.22 | 8.9% | $74.39m | |
| MNK | Mallinckrodt Plc | 0.34% | 21.90 | 21.1% | $72.27m | |
| ZGNX | Zogenix, Inc. | -0.42% | 58.95 | 11.9% | $67.46m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 0.05% | 95.73 | 21.8% | $67.42m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | -0.18% | 148.61 | 6.8% | $63.63m | |
| CTLT | Catalent Inc | 0.39% | 43.35 | 2.6% | $61.15m | |
| MDCO | Medicines Company | 0.81% | 40.08 | 21.8% | $40.02m | |
| SUPN | Supernus Pharmaceuticals, Inc. | -0.82% | 54.25 | 6.3% | $39.86m | |
| UTHR | United Therapeutics Corporation | 0.78% | 124.09 | 14.4% | $37.15m | |
| PTLA | Portola Pharmaceuticals, Inc. | -0.45% | 39.92 | 7.7% | $34.99m | |
| AERI | Aerie Pharmaceuticals, Inc. | 0.41% | 73.90 | 7.9% | $30.84m |
Company Profile
Synergy Pharmaceuticals, Inc. engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai on November 15, 2005 and is headquartered in New York, NY.